Proposing lead compounds for the development of SARS-CoV-2 receptor-binding inhibitors
Description
The COVID-19 pandemic has had deleterious effects on the world and demands urgent measures to find therapeutic agents to combat the current and related future outbreaks. The entry of SARS-CoV-2 into the host's cell is facilitated by the interaction
